Maravai Lifesciences Holdings (MRVI) Assets Average (2021 - 2026)

Maravai Lifesciences Holdings' Assets Average history runs 6 years deep, the most recent figure standing at $741.9 million for Q1 2026.

• On a quarterly basis, Assets Average fell 24.6% year-over-year to $741.9 million in Q1 2026; TTM through Mar 2026 was $741.9 million, a 24.6% decrease from a year earlier, with the FY2025 full-year figure at $889.4 million, down 28.72% from the prior year.
• Assets Average fell to $741.9 million in Q1 2026 per MRVI's latest filing, from $809.9 million in the prior quarter.
• Across five years, Assets Average topped out at $2.3 billion in Q1 2023 and bottomed at $741.9 million in Q1 2026.
• The 5-year median for Assets Average is $1.5 billion (2024), against an average of $1.6 billion.
• Across the five-year window, Assets Average soared 51.06% in 2022 and slumped 39.94% in 2024, its largest moves.
• Year by year, Assets Average stood at $2.3 billion in 2022, then fell by 17.13% to $1.9 billion in 2023, then tumbled by 39.11% to $1.1 billion in 2024, then retreated by 29.16% to $809.9 million in 2025, then dropped by 8.39% to $741.9 million in 2026.
• Per Business Quant, the three latest MRVI Assets Average figures stand at $741.9 million (Q1 2026), $809.9 million (Q4 2025), and $873.1 million (Q3 2025).